You have read all your free articles, to continue reading subscribe to read the rest of this content.
The Board of the national non-profit association for the life science industry in Sweden, SwedenBIO, has appointed Helena Strigård as their new CEO. Strigård will start her new position on September 1st 2019 and she will be replacing Jonas Ekstrand, who has been the CEO of SwedenBIO for eight yAlready…
BioInvent International has announced the appointment of Sylvie Ryckebusch as Chief Business Officer (CBO). “Sylvie Ryckebusch has already made an important contribution to the development of BioInvent’s business, including the licensing deal with CASI Pharmaceuticals in 2020, the restructuriAlready a subscriber Login You have read all your free articles, to…
Peter Hein has been appointed interim Chief Financial Officer (CFO) at Immunicum, effective May 18, 2020. “I am pleased that Peter, with his broad background from the life sciences industry combined with a deep financial knowledge has agreed to join Immunicum at this time. This facilitates a seAlready a subscriber…
The company has appointed Holger Lembrer as Chief Financial Officer, CFO. Prior to joining Oncopeptides Holger Lembrer was Business Unit CFO at Assa Abloy, and before that Investor Relations Officer, and Financial Controller. He has also been a Senior Auditor at Ernst & Young. Holger Lembrer Already a subscriber Login…
